John Robert Perfect, MD

Professor of Medicine
James B. Duke Professor of Medicine
Chief, Division of Infectious Diseases
Professor in Molecular Genetics and Microbiology
Campus mail Duke Box 102359, Durham, NC 27710
Phone (919) 684-4016
Email address perfe001@mc.duke.edu

Research in my laboratory focuses around several aspects of medical mycology. We are investigating antifungal agents (new and old) in animal models of candida and cryptococcal infections. We have examined clinical correlation of in vitro antifungal susceptibility testing and with in vivo outcome. Our basic science project examines the molecular pathogenesis of cryptococcal infections. We have developed a molecular foundation for C. neoformans, including transformation systems, gene disruptions, differential gene expression screens, and cloning pathogenesis genes. The goal of this work is to use C. neoformans as a model yeast system to identify molecular targets for antifungal drug development. There are a series of clinical trials in fungal infections which are being coordinated through this laboratory and my work also includes a series of antibiotic trials in various aspects of infections. Finally, we have now been awarded a NIH sponsored Mycology Unit for 5 years with 6 senior investigators which is focused on C. neoformans as a pathogenic model system, but will include multiple areas of medical mycology from diagnosis to treatment.

Education and Training

  • Fellow, Infectious Diseases, Duke University School of Medicine, 1977 - 1980
  • Resident, University of Michigan at Ann Arbor, 1975 - 1977
  • Intern, Riverside Methodist Hospital, 1974 - 1975
  • M.D., University of Toledo, 1974

Publications

Alspaugh, JA, and Perfect, JR. "Infections due to zygomycetes and other rare fungal opportunists." Seminars in Respiratory and Critical Care Medicine 18, no. 3 (January 1, 1997): 265-279.

Full Text

Odom, A, Del Poeta, M, Perfect, J, and Heitman, J. "The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein." Antimicrobial Agents and Chemotherapy 41, no. 1 (January 1997): 156-161.

PMID
8980772
Full Text

Alspaugh, JA, Perfect, JR, and Heitman, J. "GPA1 regulates capsule formation, melanin production, mating, and virulence in Cryptococcus neoformans." Clinical Infectious Diseases 25, no. 2 (1997): 356--.

Scholars@Duke

Cox, GM, Toffaletti, DL, and Perfect, JR. "Dominant selection system for use in Cryptococcus neoformans." Medical Mycology 34, no. 6 (December 1, 1996): 385-391.

Full Text

Cox, GM, Toffaletti, DL, and Perfect, JR. "Dominant selection system for use in Cryptococcus neoformans." Journal of Medical and Veterinary Mycology : Bi Monthly Publication of the International Society for Human and Animal Mycology 34, no. 6 (November 1996): 385-391.

PMID
8971627
Scholars@Duke

Perfect, JR, Rude, TH, Wong, B, Flynn, T, Chaturvedi, V, and Niehaus, W. "Identification of a Cryptococcus neoformans gene that directs expression of the cryptic Saccharomyces cerevisiae mannitol dehydrogenase gene." Journal of Bacteriology 178, no. 17 (September 1996): 5257-5262.

PMID
8752346
Full Text

Perfect, JR, Cox, GM, Dodge, RK, and Schell, WA. "In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans." Antimicrobial Agents and Chemotherapy 40, no. 8 (August 1996): 1910-1913.

PMID
8843302
Full Text

Salas, SD, Bennett, JE, Kwon-Chung, KJ, Perfect, JR, and Williamson, PR. "Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans." The Journal of Experimental Medicine 184, no. 2 (August 1996): 377-386.

PMID
8760791
Full Text

Fuller, RE, Drew, RH, and Perfect, JR. "Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin." Pharmacotherapy 16, no. 4 (July 1996): 584-592. (Review)

PMID
8840364
Scholars@Duke

Perfect, JR. "Fungal virulence genes as targets for antifungal chemotherapy." Antimicrobial Agents and Chemotherapy 40, no. 7 (July 1996): 1577-1583. (Review)

PMID
8807043
Full Text

Pages